/People

Fiona H. Marshall

Investor

President of Biomedical Research, Novartis at Novartis Venture Fund

Cambridge, Massachusetts, United States

Find your path to Fiona

32 people in our graph can introduce you to Fiona.

Sign up to see every warm intro you have to Fiona

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Fiona. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Fiona H. Marshall holds a PhD and serves as President of Biomedical Research at Novartis and sits on the company's Executive Committee, having joined in 2022. She previously led Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co.), and before that co-founded Heptares Therapeutics, where she was Chief Scientific Officer through its acquisition by Sosei. Earlier roles included Director of Molecular Pharmacology at Millennium Pharmaceuticals and senior positions at GSK; she earned a BSc in Biochemistry from the University of Bath and a PhD in Neuroscience from the University of Cambridge.

Invests in

Biotech

Experience

  1. NovartisPresident, Biomedical Researchcurrent2022 — presentCambridge, Massachusetts, United States
  2. MerckSenior Vice President Head of Discovery, Preclinical and Translational Medicine at Merck2021 — 2022Rahway, New Jersey, United States
  3. MerckSenior Vice President Head of Discovery Sciences and Translational Medicine2021Rahway, New Jersey, United States
  4. MerckVP Head of Neuroscience2019 — 2021West Point, Pennsylvania
  5. MSDVP Head of Discovery Research MRL UK2018 — 2019London Area, United Kingdom
  6. Sosei HeptaresExecutive Vice President and Chief Scientific Officer2015 — 2018
  7. Sosei HeptaresChief Scientific Officer and Founder of Heptares Therapeutics2006 — 2018Welwyn Garden City
  8. University of CambridgeVisiting Lecturer2002 — 2006Deptartments of Pharmacology and Chemical Engineeering
  9. F.H.Marshall ConsultancyIndependent Consultant to Venture Capital and Biotech companies2002 — 2006
  10. Millennium PharmaceuticalsDirector Biology Europe2000 — 2002Greater Cambridge Area
  11. GSKHead of Molecular Pharmacology1998 — 2000Stevenage, England, United Kingdom
  12. GSKHead of Receptor Systems Unit1995 — 1998Stevenage, England, United Kingdom
  13. GlaxoGroup Leader Neuropharmacology1989 — 1994Ware, Hertfordshire, UK

Skills & more

Drug Discovery99Lifesciences40Pharmacology62Biotechnology64Protein Chemistry26Genomics12High Throughput Screening12Oncology10GPCRs21Drug Design10Cancer Research6Biomarker Discovery3
+9 moreClinical TrialsIon ChannelsNeuropharmacologyMolecular PharmacologyDiabetesKinasesStrategyPharmaceuticsLife Sciences

From Fiona's professional profile.

Colleagues at Novartis Venture Fund

Frequently asked questions

Who is Fiona H. Marshall?
Fiona H. Marshall holds a PhD and serves as President of Biomedical Research at Novartis and sits on the company's Executive Committee, having joined in 2022. She previously led Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co.), and before that co-founded Heptares Therapeutics, where she was Chief Scientific Officer through its acquisition by Sosei. Earlier roles included Director of Molecular Pharmacology at Millennium Pharmaceuticals and senior positions at GSK; she earned a BSc in Biochemistry from the University of Bath and a PhD in Neuroscience from the University of Cambridge.
Where does Fiona H. Marshall work?
Fiona H. Marshall is President of Biomedical Research, Novartis at Novartis Venture Fund.
What does Fiona H. Marshall invest in?
Fiona H. Marshall invests in Biotech.
Where did Fiona H. Marshall go to school?
Fiona H. Marshall studied at University of Cambridge (PhD, Neuroscience); University of Bath (BSc Hons, Biochemistry).

Same school

Shared employers